Delivery Order SPE2DB24D2205-SPE2DB24FDXBM

Award Date 7/18/24
Potential Completion Date 8/8/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,195.48 contract is for the supply of 4564515079 - YONSA 125 MG TABLET 120S, with a completion date of May 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,195.48 firm-fixed-price contract is for the delivery of YONSA 125 MG tablets. The ultimate completion date for this contract is February 7, 2024. This order is not associated with a set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,690,583 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has a completion date of March 11, 2024 and a potential value of $4,390.96. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,568,078,577 units of the prescription medication YONSA 125 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a $4,542.74 Firm Fixed Price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 25, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,390.96 contract is for the supply of 4,564,133,768 units of the pharmaceutical product YONSA 125 MG TABLET 120S. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the supply of 4,568,235,544 units of the prescription medication YONSA 125 MG TABLET 120S. The delivery order is a firm fixed-price contract with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of December 11, 2024. It is not designated as a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $2,271.36 and a period of performance through April 15, 2025. The contract is a firm-fixed-price delivery order, indicating a pre-established price for the goods being provided. There is no set-aside...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDXBM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,195.48 firm fixed-price contract is for the supply of 4,565,190,069 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The delivery order is placed against a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 8, 2024.

Generated 10/17/24, 9:25 AM